Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
| Name | Class |
|---|---|
| Health Resources and Services Administration (HRSA) | FED |
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
The objective of this study is to determine whether protocol guided resuscitation of brain dead organ donors using Pulse Pressure Variation (PPV) will increase the number of organs transplanted per donor.
Specifically the study aims to:
The investigators will randomize 960 subjects to either protocolized resuscitation (n=480) using a consensus-based PPV-guided algorithm or usual care using a 1:1 randomization scheme. The primary outcome is the mean number of organs transplanted per donor. Secondary outcomes include 6mHFS (six-month hospital-free survival) in the recipients, and mean number of organs procured per donor that are suitable for transplantation (intention to transplant). The study is powered to detect a 0.5 organ increase for transplantation per donor.
Not provided
Not provided
Not provided
Not provided
Not provided
| Label | Type | Description | Intervention Names |
|---|---|---|---|
| Protocolized Care | Experimental | Algorithm to manage Pulse Pressure Variation, Cardiac Index, and Mean Arterial Pressure will be used in these donors. |
|
| Standard Care | No Intervention | This is the Organ Procurement Organization current practices. |
| Name | Type | Description | Arm Group Labels | Other Names |
|---|---|---|---|---|
| Protocolized care | Procedure | Organ Procurement Coordinators will utilize a hemodynamic monitor and algorithm for donor management of cardiac index, pulse pressure variation and mean arterial pressure. |
| Measure | Description | Time Frame |
|---|---|---|
| Number of organs transplanted. | At explantation |
| Measure | Description | Time Frame |
|---|---|---|
| Number of organs that are transplantable. | At Explantation | |
| Expected Observed Ratio | At Explantation | |
| Organ Recipient six month hospital free survival |
Not provided
Inclusion Criteria:
Exclusion criteria:
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
| Name | Affiliation | Role |
|---|---|---|
| John Kellum, MD | University of Pittsburgh | Principal Investigator |
| Facility | Status | City | State | ZIP | Country | Contacts |
|---|---|---|---|---|---|---|
| LifeLink of Georgia | Norcross | Georgia | 30071 | United States | ||
| LifeBanc |
| PubMed Identifier | Type | Citation | Retractions |
|---|---|---|---|
| 23944211 | Background | Al-Khafaji A, Murugan R, Wahed AS, Lebovitz DJ, Souter MJ, Kellum JA; MOnIToR study investigators. Monitoring Organ Donors to Improve Transplantation Results (MOnIToR) trial methodology. Crit Care Resusc. 2013 Sep;15(3):234-40. | |
| 25583616 | Result | Al-Khafaji A, Elder M, Lebovitz DJ, Murugan R, Souter M, Stuart S, Wahed AS, Keebler B, Dils D, Mitchell S, Shutterly K, Wilkerson D, Pearse R, Kellum JA. Protocolized fluid therapy in brain-dead donors: the multicenter randomized MOnIToR trial. Intensive Care Med. 2015 Mar;41(3):418-26. doi: 10.1007/s00134-014-3621-0. Epub 2015 Jan 13. |
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
| 6 months post transplant |
| Cleveland |
| Ohio |
| 44122 |
| United States |
| Lifeline of Ohio | Columbus | Ohio | 43212 | United States |
| LifeShare of Oklahoma | Oklahoma City | Oklahoma | 73116 | United States |
| Center for Organ Recovey and Education | Pittsburgh | Pennsylvania | 15238 | United States |
| Tennessee Donor Services | Knoxville | Tennessee | 37909 | United States |
| Southwest Transplant Alliance-Dallas | Dallas | Texas | 75231 | United States |
| Lifecenter North West | Bellevue | Washington | 98004 | United States |
| 30172032 | Derived | Li S, Wang S, Murugan R, Al-Khafaji A, Lebovitz DJ, Souter M, Stuart SRN, Kellum JA; Monitoring Organ Donors to Improve Transplantation Results (MOnIToR) Study Investigators. Donor biomarkers as predictors of organ use and recipient survival after neurologically deceased donor organ transplantation. J Crit Care. 2018 Dec;48:42-47. doi: 10.1016/j.jcrc.2018.08.013. Epub 2018 Aug 18. |